Editorial Expression of Concern: Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells.
Saved in:
| Title: | Editorial Expression of Concern: Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells. |
|---|---|
| Authors: | Andrews DM; Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia. daniel.andrews@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. daniel.andrews@petermac.org., Sullivan LC; Department of Microbiology and Immunology, University of Melbourne, Parkville, Australia., Baschuk N; Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia., Chan CJ; Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia.; Department of Pathology and Immunology, Monash University, Prahran, Australia., Berry R; Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Australia., Cotterell CL; Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia., Lin J; Department of Microbiology and Immunology, University of Melbourne, Parkville, Australia., Halse H; Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia., Watt SV; Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia., Poursine-Laurent J; Rheumatology Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA., Wang CR; Department of Microbiology and Immunology, Northwestern University, Chicago, Illinois, USA., Scalzo AA; Centre for Ophthalmology and Vision Science, University of Western Australia, Crawley, Australia.; Centre for Experimental Immunology, Lions Eye Institute, Nedlands, Australia., Yokoyama WM; Rheumatology Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.; Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri, USA., Rossjohn J; Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Australia., Brooks AG; Department of Microbiology and Immunology, University of Melbourne, Parkville, Australia., Smyth MJ; Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia. mark.smyth@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. mark.smyth@petermac.org.; Department of Pathology and Immunology, Monash University, Prahran, Australia. mark.smyth@petermac.org. |
| Source: | Nature immunology [Nat Immunol] 2026 Jun 29. Date of Electronic Publication: 2026 Jun 29. |
| Publication Type: | Expression of Concern |
| Journal Info: | Publisher: Nature America Inc Country of Publication: United States NLM ID: 100941354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1529-2916 (Electronic) Linking ISSN: 15292908 NLM ISO Abbreviation: Nat Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42373988 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Editorial Expression of Concern: Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Andrews+DM%22">Andrews DM</searchLink>; Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia. daniel.andrews@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. daniel.andrews@petermac.org.<br /><searchLink fieldCode="AU" term="%22Sullivan+LC%22">Sullivan LC</searchLink>; Department of Microbiology and Immunology, University of Melbourne, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Baschuk+N%22">Baschuk N</searchLink>; Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Chan+CJ%22">Chan CJ</searchLink>; Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia.; Department of Pathology and Immunology, Monash University, Prahran, Australia.<br /><searchLink fieldCode="AU" term="%22Berry+R%22">Berry R</searchLink>; Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Australia.<br /><searchLink fieldCode="AU" term="%22Cotterell+CL%22">Cotterell CL</searchLink>; Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Lin+J%22">Lin J</searchLink>; Department of Microbiology and Immunology, University of Melbourne, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Halse+H%22">Halse H</searchLink>; Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Watt+SV%22">Watt SV</searchLink>; Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Poursine-Laurent+J%22">Poursine-Laurent J</searchLink>; Rheumatology Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Wang+CR%22">Wang CR</searchLink>; Department of Microbiology and Immunology, Northwestern University, Chicago, Illinois, USA.<br /><searchLink fieldCode="AU" term="%22Scalzo+AA%22">Scalzo AA</searchLink>; Centre for Ophthalmology and Vision Science, University of Western Australia, Crawley, Australia.; Centre for Experimental Immunology, Lions Eye Institute, Nedlands, Australia.<br /><searchLink fieldCode="AU" term="%22Yokoyama+WM%22">Yokoyama WM</searchLink>; Rheumatology Division, Department of Medicine, Washington University School of Medicine, St. Louis, Missouri, USA.; Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri, USA.<br /><searchLink fieldCode="AU" term="%22Rossjohn+J%22">Rossjohn J</searchLink>; Department of Biochemistry and Molecular Biology, School of Biomedical Sciences, Monash University, Clayton, Australia.<br /><searchLink fieldCode="AU" term="%22Brooks+AG%22">Brooks AG</searchLink>; Department of Microbiology and Immunology, University of Melbourne, Parkville, Australia.<br /><searchLink fieldCode="AU" term="%22Smyth+MJ%22">Smyth MJ</searchLink>; Cancer Immunology Program, Trescowthick Laboratories, Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Australia. mark.smyth@petermac.org.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia. mark.smyth@petermac.org.; Department of Pathology and Immunology, Monash University, Prahran, Australia. mark.smyth@petermac.org. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22100941354%22">Nature immunology</searchLink> [Nat Immunol] 2026 Jun 29. <i>Date of Electronic Publication: </i>2026 Jun 29. – Name: TypePub Label: Publication Type Group: TypPub Data: Expression of Concern – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+America+Inc%22">Nature America Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>100941354 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1529-2916 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215292908%22">15292908 </searchLink><i>NLM ISO Abbreviation: </i>Nat Immunol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42373988 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41590-026-02597-1 Languages: – Code: eng Text: English Titles: – TitleFull: Editorial Expression of Concern: Recognition of the nonclassical MHC class I molecule H2-M3 by the receptor Ly49A regulates the licensing and activation of NK cells. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Andrews DM – PersonEntity: Name: NameFull: Sullivan LC – PersonEntity: Name: NameFull: Baschuk N – PersonEntity: Name: NameFull: Chan CJ – PersonEntity: Name: NameFull: Berry R – PersonEntity: Name: NameFull: Cotterell CL – PersonEntity: Name: NameFull: Lin J – PersonEntity: Name: NameFull: Halse H – PersonEntity: Name: NameFull: Watt SV – PersonEntity: Name: NameFull: Poursine-Laurent J – PersonEntity: Name: NameFull: Wang CR – PersonEntity: Name: NameFull: Scalzo AA – PersonEntity: Name: NameFull: Yokoyama WM – PersonEntity: Name: NameFull: Rossjohn J – PersonEntity: Name: NameFull: Brooks AG – PersonEntity: Name: NameFull: Smyth MJ IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 06 Text: 2026 Jun 29 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1529-2916 Titles: – TitleFull: Nature immunology Type: main |
| ResultId | 1 |
